Hylios
HomeIntelligencePricingResourcesNews
LoginFree daily briefStart a Pilot
Back to Intelligence

#generic-drugs

(3 articles)
Trade Policy & Tariffs
High ImpactAug 20, 2026

Trump's Staggered Generic Drug Tariffs Reshape Pharma Supply

The Trump administration has announced plans to implement staggered tariffs on generic pharmaceutical drugs, signaling a major shift in U.S. trade policy toward the pharmaceutical sector. This policy

Vinanet#pharmaceutical-tariffs#generic-drugs#trade-policy
Trade Policy & Tariffs
High ImpactAug 11, 2026

Trump Tariffs on Generic Drug Makers Threaten Supply Chain

President Trump has announced plans to impose new tariffs on generic drug manufacturers, with implementation scheduled for two years hence. This policy proposal represents a significant shift in pharm

BNN Bloomberg#tariffs-pharmaceuticals#generic-drugs#trade-policy
Trade Policy & Tariffs
High ImpactJul 22, 2026

Trump's 200% Generic Drug Tariffs Threaten Pharma Supply Chains

The Trump administration's proposal to impose 200% tariffs on generic pharmaceuticals represents a structural shift in pharmaceutical trade policy with far-reaching supply chain consequences. The anno

Supply Chain Dive#pharma-tariffs#trade-policy#generic-drugs

Hylios

Hylios - Better Decisions. Made Faster.

Newsletter

The daily supply chain brief, free. Unsubscribe any time.

Product

  • Features
  • Shipper Network Diagnostic
  • Deal Intelligence
  • Demand Intelligence
  • For Carriers
  • Tariff Exposure
  • Pricing
  • Design Partners
  • Documentation

Guides

  • Digital Twin Guide
  • Simulation Guide
  • Modeling Guide
  • Sandbox Guide
  • Intelligence Buyer's Guide
  • Hylios vs Alternatives
  • Methodology

Company

  • About
  • News
  • Careers

Legal

  • Privacy Policy
  • Terms of Service
© 2026 Hylios. All rights reserved.